سرمایه گذاری در بازار تغییر دادن تاریخ
Acadia Pharmaceuticals USD 4.52B 919M 2025-12
Agios Pharmaceuticals USD 1.59B 745M 2025-12
Akebia Therapeutics USD 427M 297M 2025-12
Almirall EUR 2.76B 472.53M 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amarin USD 290M 51M 2025-12
Ardelyx USD 1.42B 89M 2025-12
AstraZeneca USD 288.15B 55.08B 2025-12
Charles River Laboratories USD 10.02B 2.71B 2025-12
Coherus Biosciences USD 172M 19M 2025-12
Emergent BioSolutions USD 125M 51M 2023-12
Esperion Therapeutics USD 885M 351M 2025-12
Halozyme Therapeutics USD 7.91B 664M 2025-12
Incyte USD 19.39B 2.83B 2025-12
Karyopharm Therapeutics USD 652M 517M 2026-04
Lexicon Pharmaceuticals USD 418M 73M 2025-12
MacroGenics USD 102M 4M 2025-12
Myriad Genetics USD 575M 98M 2025-12
Pacira USD 1.06B 94M 2025-12
PTC Therapeutics USD 6.1B 1.22B 2025-12
Sarepta Therapeutics USD 2.26B 238M 2025-12
Takeda JPY 7.64T 774.9B 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Vanda Pharmaceuticals USD 279M 6M 2024-12